Elequin Capital LP Innoviva, Inc. Transaction History

Elequin Capital LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$17.1 - $21.8 $427 - $545	25 New	25 $0
Q4 2024 Feb 14, 2025	SELL	$17.35 - $20.32 $8,067 - $9,448	-465 Reduced 99.15%	4 $0
Q3 2024 Nov 14, 2024	BUY	$16.33 - $20.04 $7,658 - $9,398	469 New	469 $9,000
Q1 2024 Mar 11, 2025	BUY	$14.56 - $16.78 $4,469 - $5,151	307 Added 7675.0%	311 $4,000
Q4 2023 Feb 14, 2024	SELL	$12.32 - $16.27 $73 - $97	-6 Reduced 30.0%	14 $0

Q3 2023 Nov 14, 2023	SELL	$12.37 - $13.89 $5,195 - $5,833	-420 Reduced 95.45%	20 $0
Q2 2023 Aug 14, 2023	BUY	$11.39 - $13.72 $5,011 - $6,036	440 New	440 $5,000

281

82.7M

13.2K

156K

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.55B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Elequin Capital LP, based on Form 13F filings with the SEC.

Stay updated on Elequin Capital LP with notifications on news.